Dr. Garvin B Smith Iii is a Moline, Illinois based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Garvin B Smith Iii as General Chiropractor is 038-007310 in Illinois. Dr. Garvin B Smith Iii is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Garvin B Smith Iii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Male
Practice Address:
2526 41st St, Moline, Illinois, 61265-5016
Phone:
309-792-7017
Fax:
309-764-9326
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1629047899
NPI Enumeration Date:
17 Mar, 2006
NPI Last Update On:
29 Sep, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Garvin B Smith Iii are as mentioned below.
License Number
Specialization
State
Status
038-007310
Chiropractor
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2526 41st St, Moline, Illinois
Zip:
61265-5016
Phone Number:
309-792-7017
Fax Number:
309-764-9326
Patients can reach Dr. Garvin B Smith Iii at 2526 41st St, Moline, Illinois or can call to book an appointment on 309-792-7017. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.